Myriad Genetics, Inc. (MYGN) NASDAQ

6.61

-0.18(-2.65%)

Updated at September 05 04:00PM

Currency In USD

Valuation

Market Cap1.24B
Enterprise Value1.28B
P/E Ratio-1.55
PEG Ratio0.01
Price/Sales Ratio0.74
Price/Book Ratio1.58
Enterprise/Revenue0.83
Enterprise/EBITDA-1.96

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.47
Operating Margin-0.5

Management Effectiveness

Return On Assets-0.58
Return On Equity-0.63

Income Statement

Revenue837.6M
Revenue/Share9
Gross Profit585.4M
EBITDA-59.5M
Net Income-127.3M
Diluted EPS-1.41

Balance Sheet

Total Cash74.4M
Total Cash/Share0.8
Total Debt154.6M
Total Debt/Equity0.4
Current Ratio1.42
Book Value Per Share4.2

Price History

52-Week Change-75.64
52-Week High29.3
52-Week Low3.76
Moving Average 50 Days5.39
Moving Average 200 Days9

Statistics

Average Volume1.73M
Shares Outstanding93.04M
% Held by Institutions83.41

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor2:1
Last Split DateMarch 26, 2009